These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8478229)

  • 21. Advantages of the Papillon protocol in the preoperative treatment of rectal carcinoma.
    Klimberg VS; Langston JD; Maners A; Gocio JC; Hutchins LF; Lang NP; Westbrook KC; Broadwater JR
    Am J Surg; 1992 Nov; 164(5):433-5; discussion 436. PubMed ID: 1443366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response.
    Mohiuddin M; Regine WF; John WJ; Hagihara PF; McGrath PC; Kenady DE; Marks G
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):883-8. PubMed ID: 10705009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined modality preoperative therapy for unresectable rectal cancer.
    Percarpio B; Bitterman J; Sabbath K; Alfano F; Ruszkowski R; Bowen J
    Conn Med; 1992 Jan; 56(1):7-9. PubMed ID: 1547634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.
    ; Ryan DP; Niedzwiecki D; Hollis D; Mediema BE; Wadler S; Tepper JE; Goldberg RM; Mayer RJ
    J Clin Oncol; 2006 Jun; 24(16):2557-62. PubMed ID: 16636336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretreatment clinical findings predict outcome for patients receiving preoperative radiation for rectal cancer.
    Myerson RJ; Singh A; Birnbaum EH; Fry RD; Fleshman JW; Kodner IJ; Lockett MA; Picus J; Walz BJ; Read TE
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):665-74. PubMed ID: 11395234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial.
    Gérard JP; Chapet O; Nemoz C; Romestaing P; Mornex F; Coquard R; Barbet N; Atlan D; Adeleine P; Freyer G
    J Clin Oncol; 2003 Mar; 21(6):1119-24. PubMed ID: 12637479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative chemoradiotherapy using concurrent capecitabine and irinotecan in magnetic resonance imaging-defined locally advanced rectal cancer: impact on long-term clinical outcomes.
    Gollins S; Sun Myint A; Haylock B; Wise M; Saunders M; Neupane R; Essapen S; Samuel L; Dougal M; Lloyd A; Morris J; Topham C; Susnerwala S
    J Clin Oncol; 2011 Mar; 29(8):1042-9. PubMed ID: 21263095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined radiation therapy, mitomycin C, and 5-fluorouracil for locally recurrent rectal carcinoma: results of a pilot study.
    Wong CS; Cummings BJ; Keane TJ; Dobrowsky W; O'Sullivan B; Catton CN
    Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1291-6. PubMed ID: 1938526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative radiotherapy with capecitabine and mitomycin C in locally advanced rectal carcinoma.
    Stojanovic S; Popov I; Radosevic-Jelic L; Micev M; Borojevic N; Nikolic V; Krivokapic Z; Kecmanovic D; Gavrilovic D; Kezic I
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):787-93. PubMed ID: 21188380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Preoperative concurrent radiochemotherapy for cancer of the rectum].
    Berger C; Kirscher S; Félix-Faure C; Chauvet B; Vincent P; Brewer Y; Reboul F
    Cancer Radiother; 1998; 2(3):260-5. PubMed ID: 9749124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy.
    Valentini V; Coco C; Minsky BD; Gambacorta MA; Cosimelli M; Bellavita R; Morganti AG; La Torre G; Trodella L; Genovesi D; Portaluri M; Maurizi-Enrici R; Barbera F; Maranzano E; Lupattelli M
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):403-12. PubMed ID: 17919844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative chemoradiation with cisplatin and 5-fluorouracil for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, sphincter preservation.
    Valentini V; Coco C; Cellini N; Picciocchi A; Rosetto ME; Mantini G; Marmiroli L; Barbaro B; Cogliandolo S; Nuzzo G; Tedesco M; Ambesi-Impiombato F; Cosimelli M; Rotman M
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1175-84. PubMed ID: 10613310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined modality preoperative therapy in poor prognostic rectal adenocarcinoma.
    Haghbin M; Sischy B; Hinson J
    Radiother Oncol; 1988 Sep; 13(1):75-81. PubMed ID: 3141984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effective surgical adjuvant therapy for high-risk rectal carcinoma.
    Krook JE; Moertel CG; Gunderson LL; Wieand HS; Collins RT; Beart RW; Kubista TP; Poon MA; Meyers WC; Mailliard JA
    N Engl J Med; 1991 Mar; 324(11):709-15. PubMed ID: 1997835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemoradiation with or without intraoperative radiation therapy in patients with locally recurrent rectal carcinoma: prognostic factors and long term outcome.
    Valentini V; Morganti AG; De Franco A; Coco C; Ratto C; Battista Doglietto G; Trodella L; Ziccarelli L; Picciocchi A; Cellini N
    Cancer; 1999 Dec; 86(12):2612-24. PubMed ID: 10594856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation.
    Díaz-González JA; Calvo FA; Cortés J; García-Sabrido JL; Gómez-Espí M; Del Valle E; Muñoz-Jiménez F; Alvarez E
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1122-8. PubMed ID: 16406393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.
    Tepper JE; O'Connell M; Niedzwiecki D; Hollis DR; Benson AB; Cummings B; Gunderson LL; Macdonald JS; Martenson JA; Mayer RJ
    J Clin Oncol; 2002 Apr; 20(7):1744-50. PubMed ID: 11919230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonsurgical management of esophageal cancer: report of a study of combined radiotherapy and chemotherapy.
    Coia LR; Engstrom PF; Paul A
    J Clin Oncol; 1987 Nov; 5(11):1783-90. PubMed ID: 2445931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant treatment in operable stage II and III rectal cancer.
    Aurelio P; Claudio C; Paolo M; Pierluigi G; Santina C; Domenico D; Numa C; Vincenzo V; Maurizio C; Fabrizio AI
    Tumori; 1995; 81(3 Suppl):109-13. PubMed ID: 7571038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studies.
    Valentini V; Coco C; Cellini N; Picciocchi A; Fares MC; Rosetto ME; Mantini G; Morganti AG; Barbaro B; Cogliandolo S; Nuzzo G; Tedesco M; Ambesi-Impiombato F; Cosimelli M; Rotman M
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):371-83. PubMed ID: 11567811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.